Thymosin Beta-4
Synthetic peptide studied in animal and cell models for wound healing and anti-inflammatory action
Last updated: March 1, 2026
- Compound
- Thymosin Beta-4
- Class
- Recovery peptide
- Summary
- Synthetic peptide studied in animal and cell models for wound healing, anti-inflammatory action, cardioprotection.
- Mechanism
- Anti-Inflammatory Resolution
- Research Status
- Phase II
- Routes Studied
- Subcutaneous injection
- Evidence Level
- Preclinical-promising · Clinically unproven
What Should You Know About Thymosin Beta-4?
- What is Thymosin Beta-4?
- Thymosin Beta-4 is a synthetic peptide studied in animal and cell models for wound healing and anti-inflammatory action.
- Is Thymosin Beta-4 clinically proven?
- No. Human evidence remains limited and does not establish Thymosin Beta-4 as clinically proven.
- What has Thymosin Beta-4 been studied for?
- Thymosin Beta-4 has been studied in preclinical models of wound healing, anti-inflammatory action, cardioprotection. These findings have not been confirmed in large-scale human trials.
- Is Thymosin Beta-4 approved?
- No. Thymosin Beta-4 is not an approved drug and remains a research compound.
What Is Thymosin Beta-4?
Thymosin Beta-4 (TB4) is a 43-amino acid peptide with the molecular formula C212H350N56O78S and a molecular weight of approximately 4921 Da. It is the most abundant member of the beta-thymosin family, a group of highly conserved peptides found in virtually all nucleated mammalian cells. First isolated from thymus tissue, Thymosin Beta-4 is now recognized as a ubiquitous intracellular peptide present at concentrations of 100-500 microM in most cell types, with...
Evidence Summary
Thymosin Beta-4 is a research compound with promising biological signals but limited human validation. Most claims exceed current clinical evidence.
Evidence Breakdown
| Domain | Evidence Level |
|---|---|
| Wound Healing | Limited |
| Anti-Inflammatory Action | Limited |
| Cardioprotection | Limited |
| Muscle Repair & Satellite Cell Activation | Limited |
| Human clinical evidence | Limited |
| Safety data | Insufficient |
Editorial Position
Thymosin Beta-4 is best understood as a compound with emerging clinical evidence that has not yet reached definitive conclusions. Many online claims exceed the strength of available human evidence, and safety data remains incomplete. Any consideration of this compound should involve careful evaluation of individual context and medical guidance.
Regulatory Status Snapshot
- Not approved as a therapeutic drug by major regulators
- Safety profile not established in large human populations
Need help interpreting this evidence for your situation?
Talk to a SpecialistA deep research review for Thymosin Beta-4 is not yet available. This compound profile is based on published peer-reviewed references listed below.
Browse all research reviewsWhat Has Thymosin Beta-4 Been Studied For?
Research areas where Thymosin Beta-4 has been investigated in published studies
-
Wound Healing Thymosin Beta-4 has been studied in animal models of wound healing. These findings have not been confirmed in controlled human trials.
-
Anti-Inflammatory Action Thymosin Beta-4 has been studied in animal models of anti-inflammatory action. These findings have not been confirmed in controlled human trials.
-
Cardioprotection Thymosin Beta-4 has been studied in animal models of cardioprotection. These findings have not been confirmed in controlled human trials.
-
Muscle Repair & Satellite Cell Activation Thymosin Beta-4 has been studied in animal models of muscle repair & satellite cell activation. These findings have not been confirmed in controlled human trials.
How Does Thymosin Beta-4 Work?
These mechanisms have been observed in preclinical models. They are plausible but have not been linked to proven clinical outcomes in humans.
- 01 G-Actin Sequestration
- 02 Extracellular Release & Paracrine Signaling
- 03 Downstream biological effect
- 04 Cell Migration & Angiogenesis
Not sure if Thymosin Beta-4 is right for you?
A specialist can review the evidence, evaluate your medical context, and help you make an informed decision about Thymosin Beta-4.
Community Reports (Anecdotal)
Experiences shared here are self-reported and do not represent clinical evidence.
Rate Thymosin Beta-4
How Is Thymosin Beta-4 Administered?
Thymosin Beta-4 is available via Subcutaneous injection. Appropriate use and protocol should be determined by a qualified specialist.
What Are the Specifications of Thymosin Beta-4?
What Conditions Has Thymosin Beta-4 Been Linked To?
Have Questions About Thymosin Beta-4?
Thymosin Beta-4 coordinates multiple healing processes simultaneously. It promotes angiogenesis (new blood vessel formation) through VEGF upregulation, stimulates cell migration through integrin-linked kinase activation, reduces inflammation by promoting M1-to-M2 macrophage polarization, and activates tissue-resident stem cells for regenerative repair.
Published studies on Thymosin Beta-4 can be found on PubMed and other peer-reviewed databases. Our references section below lists key citations.
Thymosin Beta-4 is available as a research compound in Thailand. Consult a qualified specialist to discuss whether it is appropriate for your needs.
Ready to discuss Thymosin Beta-4 with a specialist?
Get evidence-based guidance tailored to your health goals and medical context.
Book a Consultation Free initial consultation. No obligation.Reviewed by the Peptide Science Thailand Editorial Team.
Last reviewed: March 1, 2026